Pptn trifluoroacetate
CAS: 1160271-30-6
Ref. 3D-KWB27130
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Pptn trifluoroacetate
Descripción:
Pptn trifluoroacetate is a drug candidate that is currently undergoing clinical trials as a potential treatment for Alzheimer's disease. It belongs to the group of pyridone derivatives, which are chemically related to butyrophenones. Pptn trifluoroacetate has been found to be effective in reducing the symptoms of Alzheimer's disease by inhibiting 5-HT1A receptor activation, which leads to increased brain levels of serotonin and dopamine. Pptn trifluoroacetate has also been found to have calcium binding properties that lead to increased release of acetylcholine from cells in the brain. This drug candidate has shown no significant side effects in animal studies and has been found to be safe for human use.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
475.5 g/mol
Fórmula:
C29H24F3NO2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
